Minnesota · 2025-2026 Regular Session · Bill
SF 5302: Prescription drugs prices establishment subject to the Medicare Drug Price Negotiation Program
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SF 5302 is a bill introduced in the Minnesota Senate on May 16, 2026. According to its official title, it concerns: Prescription drugs prices establishment subject to the Medicare Drug Price Negotiation Program. Primary sponsor: Liz Boldon (Democratic-Farmer-Labor). It lists 2 additional sponsors. Most recent recorded action (May 16, 2026): Referred to Health and Human Services.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic-Farmer-Labor 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Liz Boldon | Primary sponsor | Democratic-Farmer-Labor | Senate | 25 |
| Rob Kupec | Co-sponsor | Democratic-Farmer-Labor | Senate | 4 |
| Erin Maye Quade | Co-sponsor | Democratic-Farmer-Labor | Senate | 56 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to Health and Human Services
- Introduction and first reading